Apollo offers clinical genomics across centres in India
Facilitated by Sapien Biosciences – a subsidiary of Apollo Hospitals, the service will be available across all centres of Apollo Hospitals and clinics in India.
Samples for clinical genomics test will be collected and processed by Sapien to build its bio-bank, followed by testing at Strand Life Sciences’ Bangalore facilities. This takes the number of hospitals offering Strand’s clinical genomics services to 50. The company incorporated in 2000 is also looking at setting up its laboratory in the US to meet the demand for its Next Generation Sequencing (NGS) services. The company received 10 million USD in Series-B funds early last year and is looking at raising funds for expansion.
“We will partner with other companies to offer similar services to detect other diseases. We are also looking at partnering with pharma companies for testing molecules,” said Jugnu Jain, co-founder of Sapien Biosciences. The Apollo Hospitals Education and Research Foundation has infused 3 million USD in Sapien and Saarum Innovation put together. Apollo Hospitals plans to extend the service for clinical genomics to its overseas hospitals. “Genomic medicine will be one of the reasons for medical tourism in India. We are looking at offering clinical genomics in countries such as Indonesia and Middle-East where there are no providers,” said Sangita Reddy, joint managing director of Apollo Hospitals Enterprise Ltd.